FOLLOW US

All Papillary Thyroid Cancer Articles

Study examines occult medullary thyroid cancer
Medullary thyroid cancer (MTC) is a relatively rare form of thyroid disease, one that is often difficult to detect, which is one reason why scientists at the Johns Hopkins University School of Medicine recently attempted to quantify the rate at which MTC goes undiscovered until a thyroidectomy.
Case report describes misdiagnosis of papillary thyroid cancer
The importance of correctly pinpointing papillary thyroid cancer (PTC) was recently highlighted in a case report describing the misdiagnosis of the disease as carcinoma of the lungs.
Medicines may one day target papillary thyroid cancer based on its genetic source
Given that thyroid cancer is a disease that originates in mutations of DNA, an Italian researcher recently reviewed the state of genomic medicine, a healthcare field that has the potential to treat malignancies at the genetic level.
Study establishes epidemiology of thyroid cancer by type, demographic group
Researchers from the National Cancer Institute (NCI) and several U.S. universities recently analyzed state-based thyroid cancer data in order to determine the incidence of each variety of the disease among American demographic groups.
Minimally invasive surgery for thyroid disease may be fit for children
Research conducted at Georgia Health Sciences University indicates that minimally invasive surgery for thyroid disease, a procedure once only used among adults, appears to have few complications for children and teens.
What is diffuse sclerosing papillary thyroid cancer? Rare and dangerous, experts say
Papillary thyroid cancer (PTC) is the thyroid gland's most common and treatable carcinoma, but new research has outlined a rare but much more serious variant of this disease.
'Decision aid' may inform people with early-stage thyroid cancer of their options
Researchers at the University of Toronto recently made a computer-based educational program to better inform people with papillary thyroid cancer of their treatment options.
Small tumors in adults over age 45 become most common form of papillary thyroid cancer
Data from the National Cancer Institute (NCI) have shown that the most common form of papillary thyroid cancer is now microcarcinomas occurring in adults over the age of 45.
Delphian node involvement may mean worse outlook for thyroid cancer
A new study has determined that when thyroid cancer metastasizes in the Delphian lymph node, there is a higher likelihood that many parts of the neck will be involved as well.
Physicians note unusual reaction to radioactive iodine after thyroidectomy
Healthcare experts say that radioactive iodine can be safely administered after a thyroidectomy because only leftover thyroid cells will absorb the isotope. However, a group of physicians recently witnessed an exception to this principle.
Radioactive iodine does not boost recurrence of thyroid cancer in Chernobyl survivors
A group of Russian and Japanese scientists has determined that people exposed to radiation during the Chernobyl disaster are unlikely to develop recurring papillary thyroid cancer as a result of subsequent treatment with radioactive iodine.
Japanese scientists analyze use of surgeries for papillary thyroid cancer
A group of scientists from Kuma Hospital, Japan, recently published a report analyzing the frequency and necessity of two common treatments for papillary thyroid cancer - the thyroidectomy and lymph node dissection.
Researchers explore atypical treatments for medullary thyroid cancer
Given that the survival rate for medullary thyroid cancer is not as optimal as those of more common forms of the disease, researchers in Germany have been exploring alternative treatments for instances in which medullary carcinomas do not respond well to radioactive iodine treatment.
Pre-operative ultrasound scans help predict outcomes of thyroid cancer patients
Among other medical tests administered to patients with thyroid diseases, ultrasound scans of the neck may accurately predict a person's post-operative health outcome, according to new scientific investigation.
Angels pitching coach is back after thyroid cancer surgery
Mike Butcher, the current pitching coach for the Los Angeles Angels, has recently recovered from papillary thyroid cancer, following surgery to remove a nodule on his thyroid gland, ESPN reports.

Don't Miss Out! Get the FREE EndocrineWeb eNewsletter!

Sign up to receive treatment and research updates, news, and helpful tips on managing your condition.
SUBSCRIBE
close X
SHOW MAIN MENU
SHOW SUB MENU